Serial Cell-Culture Passage of Severe Fever with Thrombocytopenia Syndrome Virus Attenuates Virulence and Confers Protective Immunity in Mice
Viruses · 08.03.2026 · 18 (3) · 333
DOI: 10.3390/v18030333 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 08.03.2026. Verfasst von Jihee Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Acute Viral Diseases, Center for Emerging Virus Research, National Institute of Infectious Diseases, National Institute of Health, Korea …. Hauptthemen laut MEDLINE: Severe Fever with Thrombocytopenia Syndrome, Phlebovirus, Viral Vaccines. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea National Institute of Health, National Institute of Health.
Abstract (Originalsprache)
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne viral disease with high case–fatality rates in East Asia, yet no licensed vaccines are currently available. Here, we generated attenuated severe fever with thrombocytopenia syndrome virus (SFTSV) strains through serial passage in Huh-7 cells and evaluated their pathogenicity, immunogenicity, and protective efficacy. Attenuation candidates were selected based on reduced pathogenicity, estimated based on the median lethal dose (LD50), and genetic sequencing was performed to identify mutations associated with attenuation. In C57BL/6 IFNAR−/− mice, the attenuated strain exhibited markedly reduced virulence and viral loads while inducing robust virus-specific IgG, neutralizing antibody, and cellular immune responses. Notably, immunization with the attenuated strain conferred complete protection against lethal challenge with heterologous SFTSV genotypes. Genomic analysis revealed nonsynonymous mutations in the RNA-dependent RNA polymerase (RdRp), glycoprotein, and NSs genes, implicating alterations in viral replication, entry, and immune evasion. Collectively, these findings demonstrate that serial cell-culture passage can generate attenuated SFTSV strains that retain strong immunogenicity and cross-protective efficacy, supporting their potential as live-attenuated vaccine candidates for SFTS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Acute Viral Diseases, Center for Emerging Virus Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si 28159, Republic of…
ORCID-Profile: Seok-Min Yun
Förderung
- Korea National Institute of Health
- National Institute of Health
Zitieren
APA
Kim, J., Kim, Y. E., Kang, H. J., Ryou, J., Chu, H., & Yun, S. M. (2026). Serial Cell-Culture Passage of Severe Fever with Thrombocytopenia Syndrome Virus Attenuates Virulence and Confers Protective Immunity in Mice. Viruses, 18(3), 333. https://doi.org/10.3390/v18030333
Vancouver
Kim J, Kim YE, Kang HJ, Ryou J, Chu H, Yun SM. Serial Cell-Culture Passage of Severe Fever with Thrombocytopenia Syndrome Virus Attenuates Virulence and Confers Protective Immunity in Mice. Viruses. 2026;18(3):333. doi:10.3390/v18030333
BibTeX
@article{Kim2026,
author = {Kim, Jihee and Kim, Young-Eui and Kang, Hae Ji and Ryou, Jungsang and Chu, Hyuk and Yun, Seok-Min},
title = {Serial Cell-Culture Passage of Severe Fever with Thrombocytopenia Syndrome Virus Attenuates Virulence and Confers Protective Immunity in Mice},
journal = {Viruses},
year = {2026},
volume = {18},
number = {3},
pages = {333},
doi = {10.3390/v18030333}
}
EUVIMED